Aligos Therapeutics, Inc. Quarterly Earnings Per Share, Basic in USD/shares from Q3 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Aligos Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q3 2021 to Q3 2024.
  • Aligos Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -3.07 USD/shares, a 70.4% increase year-over-year.
  • Aligos Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was 6.71 USD/shares.
  • Aligos Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -1.36 USD/shares, a 39.6% increase from 2022.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $6.71 -$3 +$7.30 +70.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 -$1 $0.03 +$0.46 Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 -$1 $0 +$0.31 +58.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$1 $9.97 +$10.50 Oct 1, 2023 Dec 31, 2023 10-K 2024-03-12
Q3 2023 -$12 -$10 -$10 -2257% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 -$2 $0 +$0.04 +8.51% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 -$2 -$1 +$0.31 +36.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$2 $1 Oct 1, 2022 Dec 31, 2022 10-K 2024-03-12
Q3 2022 $0 +$0.34 +43.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $0 Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 -$1 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q3 2021 -$1 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.